APA (7th ed.) Citation

Terpos, E., Zagouri, F., Liontos, M., Sklirou, A. D., Koutsoukos, K., Markellos, C., . . . Dimopoulos, M. (2021). Low titers of SARS-CoV-2 neutralizing antibodies after first vaccination dose in cancer patients receiving checkpoint inhibitors. Journal of Hematology & Oncology, 14(1), 1. https://doi.org/10.1186/s13045-021-01099-x

Chicago Style (17th ed.) Citation

Terpos, Evangelos, et al. "Low Titers of SARS-CoV-2 Neutralizing Antibodies After First Vaccination Dose in Cancer Patients Receiving Checkpoint Inhibitors." Journal of Hematology & Oncology 14, no. 1 (2021): 1. https://doi.org/10.1186/s13045-021-01099-x.

MLA (9th ed.) Citation

Terpos, Evangelos, et al. "Low Titers of SARS-CoV-2 Neutralizing Antibodies After First Vaccination Dose in Cancer Patients Receiving Checkpoint Inhibitors." Journal of Hematology & Oncology, vol. 14, no. 1, 2021, p. 1, https://doi.org/10.1186/s13045-021-01099-x.